| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract | 110 | 2014 | 827 | 4.680 |
Why?
|
| Lens, Crystalline | 108 | 2009 | 388 | 4.540 |
Why?
|
| Lens Nucleus, Crystalline | 21 | 2009 | 32 | 1.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 17 | 2005 | 1651 | 0.950 |
Why?
|
| Crystallins | 26 | 2001 | 75 | 0.940 |
Why?
|
| Growth Substances | 13 | 2002 | 768 | 0.850 |
Why?
|
| Astronauts | 2 | 2012 | 92 | 0.690 |
Why?
|
| Anti-Allergic Agents | 2 | 2013 | 149 | 0.680 |
Why?
|
| Space Flight | 2 | 2012 | 214 | 0.610 |
Why?
|
| Lens Cortex, Crystalline | 15 | 2009 | 21 | 0.570 |
Why?
|
| Photography | 20 | 1996 | 530 | 0.550 |
Why?
|
| Pregnadienediols | 1 | 2014 | 9 | 0.480 |
Why?
|
| Ethanolamines | 1 | 2014 | 153 | 0.450 |
Why?
|
| Beclomethasone | 2 | 2014 | 38 | 0.440 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 59 | 0.430 |
Why?
|
| Epithelial Cells | 16 | 2005 | 3665 | 0.410 |
Why?
|
| Micronutrients | 3 | 2007 | 381 | 0.390 |
Why?
|
| Antioxidants | 8 | 2007 | 1662 | 0.380 |
Why?
|
| Androstadienes | 1 | 2013 | 348 | 0.380 |
Why?
|
| Glucose | 33 | 1990 | 4336 | 0.350 |
Why?
|
| Cosmic Radiation | 1 | 2009 | 20 | 0.330 |
Why?
|
| Pregnenediones | 1 | 2008 | 29 | 0.320 |
Why?
|
| Sorbitol | 14 | 1986 | 56 | 0.320 |
Why?
|
| Ascorbic Acid | 8 | 2002 | 655 | 0.300 |
Why?
|
| Hexokinase | 12 | 1988 | 125 | 0.290 |
Why?
|
| Vitamin E | 7 | 2005 | 870 | 0.280 |
Why?
|
| Lens Capsule, Crystalline | 6 | 2009 | 39 | 0.250 |
Why?
|
| Cell Nucleus | 4 | 2003 | 2907 | 0.240 |
Why?
|
| Ophthalmology | 6 | 1997 | 549 | 0.240 |
Why?
|
| Nasal Sprays | 2 | 2014 | 20 | 0.230 |
Why?
|
| Vitamins | 7 | 2005 | 1632 | 0.230 |
Why?
|
| Aging | 24 | 2006 | 8651 | 0.220 |
Why?
|
| Glucocorticoids | 2 | 2014 | 2144 | 0.220 |
Why?
|
| Sulfhydryl Compounds | 3 | 1999 | 297 | 0.220 |
Why?
|
| Contrast Sensitivity | 3 | 1993 | 235 | 0.220 |
Why?
|
| Asthma | 2 | 2014 | 6172 | 0.210 |
Why?
|
| Cataract Extraction | 5 | 2006 | 465 | 0.190 |
Why?
|
| Phosphofructokinase-1 | 9 | 1982 | 51 | 0.190 |
Why?
|
| Peroxidases | 1 | 2001 | 134 | 0.190 |
Why?
|
| beta Carotene | 2 | 2002 | 523 | 0.190 |
Why?
|
| Phacoemulsification | 1 | 2003 | 149 | 0.190 |
Why?
|
| Aldehyde Reductase | 6 | 1984 | 71 | 0.180 |
Why?
|
| Sugar Alcohol Dehydrogenases | 5 | 1984 | 12 | 0.180 |
Why?
|
| Visual Acuity | 9 | 2006 | 2642 | 0.180 |
Why?
|
| Disulfides | 2 | 1999 | 465 | 0.180 |
Why?
|
| Protein S | 1 | 1999 | 30 | 0.170 |
Why?
|
| Hydrogen Peroxide | 8 | 2001 | 728 | 0.170 |
Why?
|
| Diet Surveys | 6 | 2007 | 1161 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3217 | 0.160 |
Why?
|
| Oxidative Stress | 5 | 2005 | 3100 | 0.160 |
Why?
|
| Double-Blind Method | 6 | 2014 | 12262 | 0.150 |
Why?
|
| Dietary Supplements | 4 | 2007 | 3388 | 0.150 |
Why?
|
| Cattle | 18 | 2000 | 3846 | 0.140 |
Why?
|
| X-Rays | 2 | 2010 | 307 | 0.140 |
Why?
|
| Vision Tests | 2 | 1995 | 158 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 6 | 2005 | 5779 | 0.140 |
Why?
|
| Rabbits | 19 | 2000 | 4771 | 0.130 |
Why?
|
| Fructose | 8 | 1986 | 287 | 0.130 |
Why?
|
| Light | 13 | 2001 | 1345 | 0.130 |
Why?
|
| Body Water | 2 | 1986 | 341 | 0.120 |
Why?
|
| Microscopy | 1 | 2000 | 884 | 0.120 |
Why?
|
| Metered Dose Inhalers | 1 | 2014 | 25 | 0.120 |
Why?
|
| Imidazolidines | 3 | 1984 | 38 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 1705 | 0.120 |
Why?
|
| Aged | 57 | 2014 | 168217 | 0.120 |
Why?
|
| Carotenoids | 3 | 2002 | 620 | 0.120 |
Why?
|
| Heat-Shock Proteins | 6 | 2005 | 795 | 0.120 |
Why?
|
| Middle Aged | 58 | 2014 | 219560 | 0.120 |
Why?
|
| Humans | 136 | 2014 | 758381 | 0.110 |
Why?
|
| Transcriptional Activation | 4 | 2005 | 1753 | 0.110 |
Why?
|
| Macular Degeneration | 3 | 2007 | 1001 | 0.110 |
Why?
|
| Animals | 79 | 2005 | 167777 | 0.110 |
Why?
|
| Eye | 4 | 1990 | 710 | 0.110 |
Why?
|
| Lovastatin | 1 | 1993 | 116 | 0.110 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 107 | 0.110 |
Why?
|
| Glycemic Index | 2 | 2006 | 393 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 4 | 1997 | 1870 | 0.110 |
Why?
|
| Heparin | 1 | 2000 | 1632 | 0.110 |
Why?
|
| Autoimmunity | 2 | 2000 | 1358 | 0.100 |
Why?
|
| Epistaxis | 1 | 2013 | 111 | 0.100 |
Why?
|
| Radiation Injuries | 2 | 2009 | 1182 | 0.100 |
Why?
|
| Freezing | 4 | 1986 | 306 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2005 | 8946 | 0.100 |
Why?
|
| Administration, Intranasal | 1 | 2013 | 471 | 0.100 |
Why?
|
| Rats | 32 | 2003 | 23681 | 0.090 |
Why?
|
| Tryptophan | 4 | 2000 | 479 | 0.090 |
Why?
|
| Scattering, Radiation | 9 | 1999 | 488 | 0.090 |
Why?
|
| Relative Biological Effectiveness | 1 | 2012 | 312 | 0.090 |
Why?
|
| Dietary Carbohydrates | 2 | 2006 | 890 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 4 | 2003 | 1705 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2005 | 11471 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 881 | 0.090 |
Why?
|
| Diabetes Complications | 5 | 2003 | 1317 | 0.090 |
Why?
|
| Choroid | 4 | 1982 | 350 | 0.090 |
Why?
|
| Hypoglycemia | 4 | 1989 | 881 | 0.090 |
Why?
|
| Medical History Taking | 1 | 1994 | 772 | 0.090 |
Why?
|
| Hot Temperature | 5 | 2000 | 1434 | 0.090 |
Why?
|
| COS Cells | 5 | 2004 | 1128 | 0.090 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2009 | 15 | 0.080 |
Why?
|
| Adult | 37 | 2014 | 219916 | 0.080 |
Why?
|
| Adenosine Triphosphate | 14 | 1986 | 1986 | 0.080 |
Why?
|
| Culture Media | 4 | 1989 | 899 | 0.080 |
Why?
|
| Epithelium | 8 | 2000 | 1605 | 0.080 |
Why?
|
| Uveitis, Anterior | 6 | 1986 | 102 | 0.080 |
Why?
|
| Intraocular Pressure | 2 | 2013 | 1288 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 1994 | 1338 | 0.080 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2001 | 203 | 0.080 |
Why?
|
| Riboflavin | 3 | 2005 | 105 | 0.080 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2008 | 24 | 0.080 |
Why?
|
| Photobleaching | 1 | 2008 | 29 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 5 | 1993 | 1628 | 0.080 |
Why?
|
| Aircraft | 1 | 2009 | 125 | 0.080 |
Why?
|
| Proteins | 3 | 2001 | 6026 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2014 | 2020 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2000 | 1743 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10747 | 0.080 |
Why?
|
| Longitudinal Studies | 10 | 2012 | 14481 | 0.070 |
Why?
|
| Lighting | 1 | 1990 | 211 | 0.070 |
Why?
|
| RNA, Messenger | 7 | 2004 | 12760 | 0.070 |
Why?
|
| Diabetes Mellitus | 6 | 1993 | 5818 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2008 | 3734 | 0.070 |
Why?
|
| Rats, Inbred Strains | 9 | 1989 | 2090 | 0.070 |
Why?
|
| Vimentin | 1 | 2008 | 255 | 0.070 |
Why?
|
| Nutrition Assessment | 3 | 2007 | 726 | 0.070 |
Why?
|
| Retina | 5 | 2003 | 2637 | 0.070 |
Why?
|
| Superoxides | 2 | 2000 | 386 | 0.070 |
Why?
|
| Cells, Cultured | 9 | 2004 | 18942 | 0.070 |
Why?
|
| Phototherapy | 1 | 1990 | 368 | 0.070 |
Why?
|
| Ciliary Body | 3 | 2003 | 166 | 0.070 |
Why?
|
| Immune Sera | 1 | 1987 | 613 | 0.070 |
Why?
|
| Female | 53 | 2014 | 390316 | 0.070 |
Why?
|
| Sugar Alcohols | 2 | 1984 | 17 | 0.070 |
Why?
|
| Autoantibodies | 4 | 2000 | 2118 | 0.070 |
Why?
|
| Sodium Chloride | 4 | 2003 | 588 | 0.070 |
Why?
|
| Glycosides | 2 | 1984 | 100 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2001 | 11894 | 0.070 |
Why?
|
| Hydroxides | 1 | 1986 | 46 | 0.070 |
Why?
|
| alpha-Linolenic Acid | 1 | 2007 | 144 | 0.070 |
Why?
|
| Lasers | 2 | 1990 | 952 | 0.070 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2005 | 14 | 0.070 |
Why?
|
| Molecular Weight | 9 | 1994 | 2185 | 0.070 |
Why?
|
| Diet Records | 2 | 2005 | 427 | 0.070 |
Why?
|
| Heavy Ions | 1 | 2005 | 11 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4839 | 0.070 |
Why?
|
| Aqueous Humor | 2 | 2003 | 153 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 418 | 0.060 |
Why?
|
| Nuclear Localization Signals | 1 | 2005 | 77 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 224 | 0.060 |
Why?
|
| Oxidation-Reduction | 7 | 2000 | 2222 | 0.060 |
Why?
|
| Aged, 80 and over | 14 | 2008 | 58681 | 0.060 |
Why?
|
| Male | 48 | 2014 | 358742 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2001 | 1090 | 0.060 |
Why?
|
| Isoenzymes | 3 | 2004 | 1686 | 0.060 |
Why?
|
| Photochemotherapy | 2 | 1990 | 819 | 0.060 |
Why?
|
| Visual Perception | 1 | 1993 | 1374 | 0.060 |
Why?
|
| Lactates | 5 | 1986 | 404 | 0.060 |
Why?
|
| Ocular Hypertension | 1 | 2006 | 206 | 0.060 |
Why?
|
| Ultraviolet Rays | 4 | 1988 | 1076 | 0.060 |
Why?
|
| Spectrophotometry | 5 | 1987 | 310 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1793 | 0.060 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2004 | 87 | 0.060 |
Why?
|
| Tissue Preservation | 2 | 1983 | 174 | 0.060 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2004 | 111 | 0.060 |
Why?
|
| Phosphates | 3 | 1984 | 771 | 0.060 |
Why?
|
| Thiamine | 1 | 2005 | 160 | 0.060 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2004 | 146 | 0.060 |
Why?
|
| Base Sequence | 7 | 2005 | 12436 | 0.060 |
Why?
|
| Glucosephosphates | 5 | 1988 | 20 | 0.060 |
Why?
|
| Uveal Diseases | 2 | 1982 | 45 | 0.060 |
Why?
|
| Vitreous Body | 4 | 1988 | 399 | 0.060 |
Why?
|
| Glutathione | 3 | 1999 | 579 | 0.050 |
Why?
|
| Zinc | 1 | 2007 | 687 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2004 | 1317 | 0.050 |
Why?
|
| NADP | 6 | 1986 | 222 | 0.050 |
Why?
|
| Glycerophosphates | 4 | 1988 | 47 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2000 | 426 | 0.050 |
Why?
|
| Disease Progression | 4 | 2012 | 13468 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 4 | 1998 | 681 | 0.050 |
Why?
|
| Lens Diseases | 1 | 1982 | 13 | 0.050 |
Why?
|
| Microphthalmos | 1 | 1982 | 58 | 0.050 |
Why?
|
| Peroxiredoxin VI | 1 | 2001 | 4 | 0.050 |
Why?
|
| Transfection | 4 | 2008 | 5779 | 0.050 |
Why?
|
| Abdominal Wall | 1 | 2003 | 165 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 4567 | 0.050 |
Why?
|
| Kinetics | 9 | 1986 | 6371 | 0.050 |
Why?
|
| DNA Footprinting | 1 | 2001 | 97 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 540 | 0.050 |
Why?
|
| Pigmentation | 2 | 1999 | 144 | 0.050 |
Why?
|
| Peroxiredoxins | 1 | 2001 | 51 | 0.050 |
Why?
|
| Imidazoles | 3 | 1984 | 1179 | 0.050 |
Why?
|
| Circular Dichroism | 3 | 1987 | 344 | 0.050 |
Why?
|
| Tretinoin | 1 | 2004 | 519 | 0.050 |
Why?
|
| Isoquinolines | 2 | 1980 | 351 | 0.050 |
Why?
|
| Molecular Sequence Data | 7 | 2003 | 17617 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2002 | 250 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2009 | 1956 | 0.050 |
Why?
|
| Down-Regulation | 3 | 2003 | 2905 | 0.050 |
Why?
|
| Oxidants | 1 | 2001 | 169 | 0.050 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2001 | 88 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.050 |
Why?
|
| 3-Hydroxyanthranilic Acid | 1 | 2000 | 8 | 0.050 |
Why?
|
| Protein Binding | 5 | 2008 | 9312 | 0.050 |
Why?
|
| Luminescent Proteins | 4 | 2008 | 835 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2008 | 3096 | 0.040 |
Why?
|
| Women's Health | 3 | 2005 | 2057 | 0.040 |
Why?
|
| Protons | 1 | 2005 | 1112 | 0.040 |
Why?
|
| Solubility | 6 | 1988 | 1087 | 0.040 |
Why?
|
| Potassium | 7 | 1983 | 1310 | 0.040 |
Why?
|
| Prevalence | 9 | 2007 | 15646 | 0.040 |
Why?
|
| Kynurenine | 1 | 2000 | 139 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2000 | 179 | 0.040 |
Why?
|
| Methods | 4 | 1989 | 1074 | 0.040 |
Why?
|
| Keratinocytes | 2 | 2002 | 790 | 0.040 |
Why?
|
| Photochemistry | 3 | 1990 | 239 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 3 | 1983 | 210 | 0.040 |
Why?
|
| Eye Burns | 1 | 1979 | 65 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1900 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1989 | 1539 | 0.040 |
Why?
|
| Exudates and Transudates | 2 | 1981 | 174 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2009 | 1809 | 0.040 |
Why?
|
| Case-Control Studies | 8 | 1999 | 22031 | 0.040 |
Why?
|
| Catalase | 3 | 1988 | 216 | 0.040 |
Why?
|
| NAD | 4 | 1988 | 609 | 0.040 |
Why?
|
| Organ Culture Techniques | 4 | 1989 | 795 | 0.040 |
Why?
|
| Glycolysis | 5 | 1981 | 826 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 564 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 1995 | 20052 | 0.040 |
Why?
|
| DNA | 4 | 2005 | 7199 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1133 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 869 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2000 | 981 | 0.040 |
Why?
|
| Retinal Detachment | 1 | 1982 | 428 | 0.040 |
Why?
|
| Brain | 1 | 2004 | 26951 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 4 | 2008 | 2057 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1527 | 0.040 |
Why?
|
| Cell Separation | 1 | 1983 | 1720 | 0.040 |
Why?
|
| Muramidase | 1 | 1977 | 169 | 0.040 |
Why?
|
| Cornea | 2 | 2003 | 1326 | 0.040 |
Why?
|
| Observer Variation | 2 | 1993 | 2600 | 0.040 |
Why?
|
| Age Factors | 11 | 2002 | 18357 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10146 | 0.040 |
Why?
|
| Eye Diseases | 3 | 1978 | 651 | 0.040 |
Why?
|
| Fluorescence | 3 | 1999 | 749 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2005 | 1991 | 0.040 |
Why?
|
| Eyelids | 1 | 1979 | 277 | 0.040 |
Why?
|
| Fructosephosphates | 5 | 1988 | 14 | 0.040 |
Why?
|
| Galactosemias | 3 | 1980 | 124 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 2018 | 0.030 |
Why?
|
| Retinal Degeneration | 1 | 2001 | 412 | 0.030 |
Why?
|
| Biological Transport | 2 | 2000 | 2084 | 0.030 |
Why?
|
| Boston | 6 | 2006 | 9304 | 0.030 |
Why?
|
| Polymers | 1 | 1984 | 1615 | 0.030 |
Why?
|
| Temperature | 3 | 1983 | 2219 | 0.030 |
Why?
|
| Retinal Drusen | 2 | 2007 | 74 | 0.030 |
Why?
|
| Young Adult | 3 | 2014 | 58808 | 0.030 |
Why?
|
| Colorimetry | 2 | 1993 | 148 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15785 | 0.030 |
Why?
|
| Ophthalmic Assistants | 1 | 1975 | 2 | 0.030 |
Why?
|
| Chromatography, Gel | 3 | 1985 | 645 | 0.030 |
Why?
|
| Eye Manifestations | 1 | 1975 | 10 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6233 | 0.030 |
Why?
|
| Cell Count | 1 | 2000 | 1835 | 0.030 |
Why?
|
| Metals | 1 | 2000 | 717 | 0.030 |
Why?
|
| Autoantigens | 1 | 2000 | 877 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2002 | 1206 | 0.030 |
Why?
|
| Adolescent | 5 | 2014 | 87888 | 0.030 |
Why?
|
| Hexosephosphates | 2 | 1986 | 26 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 1957 | 0.030 |
Why?
|
| Peptides | 1 | 1987 | 4341 | 0.030 |
Why?
|
| Time Factors | 8 | 2007 | 39873 | 0.030 |
Why?
|
| United States | 7 | 2009 | 72140 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 8144 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 1975 | 235 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 1986 | 3758 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2014 | 64379 | 0.030 |
Why?
|
| Odds Ratio | 6 | 2006 | 9650 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 1986 | 543 | 0.030 |
Why?
|
| Diet | 5 | 2007 | 8003 | 0.030 |
Why?
|
| Osmotic Pressure | 2 | 1986 | 137 | 0.030 |
Why?
|
| Gene Expression | 2 | 2004 | 7583 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1153 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2004 | 2685 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2002 | 3993 | 0.030 |
Why?
|
| Protein Conformation | 3 | 1987 | 3966 | 0.030 |
Why?
|
| Consensus Sequence | 2 | 2005 | 365 | 0.030 |
Why?
|
| Refraction, Ocular | 2 | 2006 | 179 | 0.030 |
Why?
|
| Glaucoma | 3 | 1981 | 1182 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 2646 | 0.030 |
Why?
|
| Physician Assistants | 1 | 1975 | 188 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1997 | 1351 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2009 | 25953 | 0.030 |
Why?
|
| Adipose Tissue | 2 | 2003 | 3299 | 0.030 |
Why?
|
| Body Weight | 1 | 2003 | 4603 | 0.030 |
Why?
|
| Cell Survival | 5 | 2001 | 5781 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1997 | 1066 | 0.030 |
Why?
|
| Europe | 2 | 1995 | 3420 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 1993 | 377 | 0.030 |
Why?
|
| Color Perception | 1 | 1993 | 212 | 0.020 |
Why?
|
| Sodium | 5 | 1978 | 1588 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6293 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 1973 | 325 | 0.020 |
Why?
|
| Osmolar Concentration | 3 | 1987 | 660 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2000 | 4114 | 0.020 |
Why?
|
| Antigens | 1 | 1997 | 1445 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1986 | 1446 | 0.020 |
Why?
|
| Risk Factors | 13 | 2006 | 73806 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 4020 | 0.020 |
Why?
|
| Calcium | 3 | 1997 | 5721 | 0.020 |
Why?
|
| Glucose-6-Phosphate | 2 | 1988 | 29 | 0.020 |
Why?
|
| Absorption | 2 | 1992 | 243 | 0.020 |
Why?
|
| Glycosylation | 2 | 1998 | 1095 | 0.020 |
Why?
|
| Research | 1 | 1978 | 1976 | 0.020 |
Why?
|
| Child | 6 | 2014 | 79813 | 0.020 |
Why?
|
| Insulin | 2 | 2003 | 6578 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2003 | 3826 | 0.020 |
Why?
|
| Galactose | 2 | 1989 | 296 | 0.020 |
Why?
|
| Reference Standards | 1 | 1993 | 1003 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1984 | 530 | 0.020 |
Why?
|
| Sex Factors | 4 | 1993 | 10505 | 0.020 |
Why?
|
| Nutritional Status | 3 | 1998 | 1607 | 0.020 |
Why?
|
| Prospective Studies | 5 | 2002 | 54136 | 0.020 |
Why?
|
| Mice | 9 | 2004 | 81107 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 1994 | 14641 | 0.020 |
Why?
|
| Iron | 3 | 2005 | 1786 | 0.020 |
Why?
|
| Nutrition Surveys | 2 | 2006 | 1718 | 0.020 |
Why?
|
| Color | 1 | 1989 | 298 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2001 | 1055 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 1514 | 0.020 |
Why?
|
| Cohort Studies | 6 | 2007 | 41252 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2000 | 4215 | 0.020 |
Why?
|
| Burns | 1 | 1979 | 1848 | 0.020 |
Why?
|
| Electrolytes | 1 | 1989 | 274 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2000 | 5031 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1983 | 2557 | 0.020 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 1987 | 16 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5098 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1977 | 2497 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 39060 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 2825 | 0.020 |
Why?
|
| Naphthalenesulfonates | 1 | 1987 | 15 | 0.020 |
Why?
|
| Allopurinol | 1 | 1989 | 198 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 4169 | 0.020 |
Why?
|
| Enzyme Activation | 4 | 1977 | 3593 | 0.020 |
Why?
|
| Fluorometry | 1 | 1987 | 100 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1993 | 2359 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2007 | 209 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 1986 | 98 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1993 | 877 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 7985 | 0.020 |
Why?
|
| Osmosis | 1 | 1986 | 103 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 1988 | 255 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 866 | 0.020 |
Why?
|
| Minerals | 1 | 1988 | 283 | 0.020 |
Why?
|
| Filtering Surgery | 1 | 2006 | 33 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 1993 | 1139 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2002 | 1991 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 491 | 0.020 |
Why?
|
| Retinal Diseases | 2 | 2007 | 702 | 0.020 |
Why?
|
| Massachusetts | 3 | 1995 | 8823 | 0.020 |
Why?
|
| Chemistry | 1 | 1986 | 348 | 0.020 |
Why?
|
| Water | 3 | 1988 | 1402 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 508 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1985 | 200 | 0.020 |
Why?
|
| Cold Temperature | 2 | 1988 | 780 | 0.020 |
Why?
|
| Mannitol | 1 | 1986 | 180 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2003 | 12876 | 0.020 |
Why?
|
| Dissection | 1 | 1987 | 297 | 0.020 |
Why?
|
| Regression Analysis | 3 | 1999 | 6353 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7843 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9418 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 1988 | 593 | 0.020 |
Why?
|
| Electrophoresis, Starch Gel | 2 | 1975 | 20 | 0.020 |
Why?
|
| Fruit | 1 | 1991 | 1159 | 0.020 |
Why?
|
| Vegetables | 1 | 1991 | 1194 | 0.020 |
Why?
|
| Sulfates | 2 | 1976 | 379 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1986 | 630 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2006 | 697 | 0.010 |
Why?
|
| Linear Energy Transfer | 1 | 2005 | 152 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 358 | 0.010 |
Why?
|
| Retinal Dehydrogenase | 1 | 2004 | 78 | 0.010 |
Why?
|
| New York | 2 | 1997 | 874 | 0.010 |
Why?
|
| Reference Values | 3 | 2003 | 4919 | 0.010 |
Why?
|
| DNA Primers | 2 | 1999 | 2816 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1982 | 1455 | 0.010 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 13447 | 0.010 |
Why?
|
| Central Nervous System Depressants | 1 | 2004 | 164 | 0.010 |
Why?
|
| Sclerosis | 1 | 1984 | 210 | 0.010 |
Why?
|
| Extracellular Space | 2 | 1997 | 564 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3712 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1983 | 94 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 1693 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 1969 | 0.010 |
Why?
|
| Nutritive Value | 1 | 2005 | 349 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1990 | 2772 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 12096 | 0.010 |
Why?
|
| Photogrammetry | 2 | 1981 | 77 | 0.010 |
Why?
|
| Electrophoresis | 2 | 1973 | 234 | 0.010 |
Why?
|
| Sodium Isotopes | 2 | 1973 | 11 | 0.010 |
Why?
|
| Rubidium | 2 | 1973 | 122 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2003 | 8544 | 0.010 |
Why?
|
| Xanthophylls | 1 | 2001 | 94 | 0.010 |
Why?
|
| Electron Probe Microanalysis | 3 | 1989 | 32 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2001 | 60 | 0.010 |
Why?
|
| Chromatids | 1 | 2001 | 63 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 818 | 0.010 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1981 | 91 | 0.010 |
Why?
|
| Eye Proteins | 2 | 1978 | 633 | 0.010 |
Why?
|
| G2 Phase | 1 | 2001 | 133 | 0.010 |
Why?
|
| Antibodies | 2 | 2001 | 2420 | 0.010 |
Why?
|
| Iritis | 1 | 1980 | 15 | 0.010 |
Why?
|
| Lutein | 1 | 2001 | 122 | 0.010 |
Why?
|
| Oils | 1 | 1981 | 56 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1982 | 348 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1982 | 1141 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 384 | 0.010 |
Why?
|
| Pyruvate Kinase | 2 | 1981 | 189 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3801 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 460 | 0.010 |
Why?
|
| Arrestin | 1 | 2000 | 30 | 0.010 |
Why?
|
| Chromones | 1 | 1980 | 148 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 458 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2000 | 143 | 0.010 |
Why?
|
| Biological Transport, Active | 2 | 1971 | 327 | 0.010 |
Why?
|
| Silicones | 1 | 1981 | 227 | 0.010 |
Why?
|
| RNA Precursors | 1 | 2001 | 212 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1981 | 534 | 0.010 |
Why?
|
| Methoxsalen | 1 | 1979 | 21 | 0.010 |
Why?
|
| G1 Phase | 1 | 2001 | 403 | 0.010 |
Why?
|
| Quercetin | 1 | 1980 | 96 | 0.010 |
Why?
|
| Radioisotopes | 2 | 1973 | 495 | 0.010 |
Why?
|
| Cell Division | 2 | 2000 | 4459 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 1171 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6520 | 0.010 |
Why?
|
| beta-Crystallin A Chain | 1 | 1999 | 1 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 1979 | 80 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2000 | 777 | 0.010 |
Why?
|
| Electroretinography | 1 | 2001 | 517 | 0.010 |
Why?
|
| Angiomatosis | 1 | 1979 | 46 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1987 | 1972 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1994 | 9266 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1980 | 344 | 0.010 |
Why?
|
| Xylose | 1 | 1978 | 28 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1543 | 0.010 |
Why?
|
| Punched-Card Systems | 1 | 1978 | 2 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3796 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1389 | 0.010 |
Why?
|
| Sclera | 2 | 1979 | 190 | 0.010 |
Why?
|
| Specimen Handling | 1 | 1983 | 707 | 0.010 |
Why?
|
| Vacuoles | 1 | 1979 | 228 | 0.010 |
Why?
|
| Ethanol | 1 | 2004 | 1325 | 0.010 |
Why?
|
| Injections | 1 | 2001 | 830 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 534 | 0.010 |
Why?
|
| Sturge-Weber Syndrome | 1 | 1979 | 85 | 0.010 |
Why?
|
| Tritium | 2 | 1981 | 707 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2001 | 1647 | 0.010 |
Why?
|
| Copper | 1 | 2000 | 366 | 0.010 |
Why?
|
| Bandages | 1 | 1979 | 269 | 0.010 |
Why?
|
| Models, Biological | 3 | 1986 | 9461 | 0.010 |
Why?
|
| Societies, Scientific | 1 | 1978 | 220 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2426 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1979 | 412 | 0.010 |
Why?
|
| Sutures | 1 | 1979 | 293 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2930 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2000 | 423 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1984 | 6347 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 978 | 0.010 |
Why?
|
| Gene Library | 1 | 2000 | 1059 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1976 | 82 | 0.010 |
Why?
|
| Debridement | 1 | 1979 | 492 | 0.010 |
Why?
|
| Solutions | 1 | 1977 | 411 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 818 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1997 | 337 | 0.010 |
Why?
|
| Incidence | 3 | 2002 | 21273 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1997 | 322 | 0.010 |
Why?
|
| Smoking | 2 | 2004 | 9042 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2001 | 1553 | 0.010 |
Why?
|
| Infant | 6 | 1997 | 36054 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1995 | 24 | 0.010 |
Why?
|
| Fasting | 1 | 1982 | 1599 | 0.010 |
Why?
|
| HLA-DR5 Antigen | 2 | 1986 | 4 | 0.010 |
Why?
|
| Mitosis | 1 | 2001 | 1191 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1995 | 24 | 0.010 |
Why?
|
| World Health Organization | 1 | 2002 | 1312 | 0.010 |
Why?
|
| Genes | 1 | 2000 | 1845 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1977 | 595 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1997 | 303 | 0.010 |
Why?
|
| Software | 1 | 1990 | 4416 | 0.010 |
Why?
|
| Papilledema | 1 | 1977 | 130 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2001 | 11070 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2753 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2176 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1976 | 202 | 0.010 |
Why?
|
| Syndrome | 1 | 1982 | 3262 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2003 | 80170 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1997 | 517 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1694 | 0.010 |
Why?
|
| Atropine | 1 | 1975 | 244 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1980 | 1368 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1975 | 333 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1978 | 769 | 0.010 |
Why?
|
| Folic Acid | 1 | 2001 | 1309 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1979 | 2114 | 0.010 |
Why?
|
| Japan | 1 | 1978 | 1366 | 0.010 |
Why?
|
| Immunization | 1 | 1999 | 1227 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1997 | 534 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 1263 | 0.010 |
Why?
|
| Scotoma | 1 | 1975 | 130 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1975 | 222 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1979 | 1083 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3443 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2003 | 2533 | 0.010 |
Why?
|
| Cell Death | 1 | 1999 | 1667 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 2387 | 0.010 |
Why?
|
| Chloroquine | 1 | 1975 | 274 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1994 | 291 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 2504 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1997 | 782 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 6036 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1973 | 242 | 0.010 |
Why?
|
| Mannose | 1 | 1973 | 121 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1973 | 9 | 0.010 |
Why?
|
| Liver | 3 | 1976 | 7502 | 0.010 |
Why?
|
| Hypotonic Solutions | 1 | 1973 | 48 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1973 | 340 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1999 | 1185 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1982 | 3680 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1978 | 1173 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1980 | 2205 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 13286 | 0.010 |
Why?
|
| Magnesium | 1 | 1976 | 809 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2000 | 1398 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1664 | 0.010 |
Why?
|
| Endophthalmitis | 1 | 1975 | 257 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1995 | 673 | 0.010 |
Why?
|
| Epitopes | 1 | 1999 | 2502 | 0.010 |
Why?
|
| Haplorhini | 1 | 1973 | 529 | 0.010 |
Why?
|
| International Cooperation | 1 | 1978 | 1430 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2882 | 0.010 |
Why?
|
| Macaca | 1 | 1973 | 409 | 0.010 |
Why?
|
| Uveitis | 1 | 1975 | 393 | 0.010 |
Why?
|
| Placenta | 1 | 1980 | 1702 | 0.010 |
Why?
|
| Hydroxychloroquine | 1 | 1975 | 426 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1997 | 1557 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1983 | 940 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1981 | 3400 | 0.010 |
Why?
|
| Myocardium | 2 | 1976 | 4690 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1971 | 316 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13276 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1971 | 422 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1969 | 51 | 0.010 |
Why?
|
| Inulin | 1 | 1969 | 68 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1984 | 3432 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 4087 | 0.010 |
Why?
|
| Amino Acids | 1 | 1995 | 1713 | 0.010 |
Why?
|
| Uric Acid | 1 | 1995 | 803 | 0.010 |
Why?
|
| Diffusion | 1 | 1971 | 813 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2001 | 3183 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 4711 | 0.000 |
Why?
|
| Dihydroxyacetone Phosphate | 1 | 1988 | 14 | 0.000 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1988 | 37 | 0.000 |
Why?
|
| Epididymis | 1 | 1970 | 227 | 0.000 |
Why?
|
| Fats | 1 | 1988 | 99 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1975 | 1927 | 0.000 |
Why?
|
| Glutarates | 1 | 1969 | 244 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6068 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1969 | 575 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1979 | 1911 | 0.000 |
Why?
|
| Organ Size | 1 | 1972 | 2252 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1988 | 410 | 0.000 |
Why?
|
| HLA-DP Antigens | 1 | 1986 | 28 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 4540 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1995 | 2413 | 0.000 |
Why?
|
| Optics and Photonics | 1 | 1987 | 304 | 0.000 |
Why?
|
| Kidney | 1 | 2001 | 7016 | 0.000 |
Why?
|
| Risk | 1 | 1998 | 9599 | 0.000 |
Why?
|
| Fetus | 1 | 1973 | 1860 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1987 | 451 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1991 | 3425 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1977 | 4158 | 0.000 |
Why?
|
| India | 1 | 1991 | 2329 | 0.000 |
Why?
|
| Freeze Fracturing | 1 | 1983 | 68 | 0.000 |
Why?
|
| Glutathione Disulfide | 1 | 1983 | 33 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1998 | 12440 | 0.000 |
Why?
|
| Research Design | 1 | 1978 | 6154 | 0.000 |
Why?
|
| Child, Preschool | 3 | 1986 | 42058 | 0.000 |
Why?
|
| Sulfur | 1 | 1982 | 163 | 0.000 |
Why?
|
| Borohydrides | 1 | 1981 | 32 | 0.000 |
Why?
|
| Fructosediphosphates | 1 | 1981 | 24 | 0.000 |
Why?
|
| Xylitol | 1 | 1981 | 23 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1980 | 18125 | 0.000 |
Why?
|
| Phosphorus | 1 | 1982 | 335 | 0.000 |
Why?
|
| Refractometry | 1 | 1981 | 57 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 29915 | 0.000 |
Why?
|
| Cyanides | 1 | 1981 | 82 | 0.000 |
Why?
|
| Postoperative Complications | 2 | 1981 | 15638 | 0.000 |
Why?
|
| Haploidy | 1 | 1980 | 133 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1983 | 859 | 0.000 |
Why?
|
| Lysine | 1 | 1984 | 998 | 0.000 |
Why?
|
| Eye Protective Devices | 1 | 1979 | 33 | 0.000 |
Why?
|
| Mass Screening | 1 | 1975 | 5425 | 0.000 |
Why?
|
| Venous Pressure | 1 | 1979 | 57 | 0.000 |
Why?
|
| Psychometrics | 1 | 1989 | 3050 | 0.000 |
Why?
|
| Phosphoenolpyruvate | 1 | 1978 | 16 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1978 | 26182 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1984 | 2381 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1433 | 0.000 |
Why?
|
| Pregnancy | 1 | 1980 | 29742 | 0.000 |
Why?
|
| Anterior Chamber | 1 | 1979 | 194 | 0.000 |
Why?
|
| Steroids | 1 | 1983 | 926 | 0.000 |
Why?
|
| Enzyme Reactivators | 1 | 1977 | 6 | 0.000 |
Why?
|
| Body Fluids | 1 | 1979 | 319 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1991 | 7817 | 0.000 |
Why?
|
| Drug Stability | 1 | 1977 | 290 | 0.000 |
Why?
|
| Oxygen | 1 | 1988 | 4192 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1991 | 4411 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1986 | 4284 | 0.000 |
Why?
|
| Drainage | 1 | 1981 | 1161 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1987 | 3561 | 0.000 |
Why?
|
| Genotype | 1 | 1986 | 12945 | 0.000 |
Why?
|
| Phenotype | 1 | 1986 | 16534 | 0.000 |
Why?
|
| Skin | 1 | 1979 | 4464 | 0.000 |
Why?
|